Person—renal disease therapy, code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Renal disease therapy |
METEOR identifier: | 270264 |
Registration status: | Health, Standard 01/03/2005 |
Definition: | The therapy the person is receiving for renal disease, as represented by a code. |
Data Element Concept: | Person—renal disease therapy |
Value Domain: | Renal disease therapy code N |
Data element attributes | |
Collection and usage attributes | |
Guide for use: | More than one code can be recorded. |
---|---|
Collection methods: | To be collected on commencement of treatment and regularly reviewed. |
Source and reference attributes | |
Submitting organisation: | Cardiovascular Data Working Group |
Origin: | Caring for Australians with Renal Impairment Guidelines. Australian Kidney Foundation |
Relational attributes | |
Related metadata references: | Is re-engineered from Renal disease therapy, version 1, DE, NHDD, NHIMG, Superseded 01/03/2005.pdf (17.5 KB) No registration status |
Implementation in Data Set Specifications: | Cardiovascular disease (clinical) DSS Health, Superseded 15/02/2006 DSS specific information: Nephrotoxic agents (including radiocontrast) should be avoided where possible. Although combination ACEI and diuretic can be a very potent and efficacious means of reducing blood pressure (and thereby slowing progression), either drug should be introduced individually and carefully in a patient with underlying renal impairment. At the very least, diuretic therapy should be held or reduced when commencing an ACEI in a patient with renal impairment. Combination therapy with ACEI, diuretics and NSAIDs or COX-2 may be particularly harmful. Drugs, which are primarily excreted by the kidney (e.g. metformin, sotalol, cisapride, etc.) need to be used with caution in patients with renal impairment. The calculated GFR needs to be determined and the dose reduced or the drug avoided as appropriate. Cardiovascular disease (clinical) DSS Health, Superseded 04/07/2007 DSS specific information: Nephrotoxic agents (including radiocontrast) should be avoided where possible. Although combination ACEI and diuretic can be a very potent and efficacious means of reducing blood pressure (and thereby slowing progression), either drug should be introduced individually and carefully in a patient with underlying renal impairment. At the very least, diuretic therapy should be held or reduced when commencing an ACEI in a patient with renal impairment. Combination therapy with ACEI, diuretics and NSAIDs or COX-2 may be particularly harmful. Drugs, which are primarily excreted by the kidney (e.g. metformin, sotalol, cisapride, etc.) need to be used with caution in patients with renal impairment. The calculated GFR needs to be determined and the dose reduced or the drug avoided as appropriate. Cardiovascular disease (clinical) DSS Health, Superseded 22/12/2009 DSS specific information: Nephrotoxic agents (including radiocontrast) should be avoided where possible. Although combination ACEI and diuretic can be a very potent and efficacious means of reducing blood pressure (and thereby slowing progression), either drug should be introduced individually and carefully in a patient with underlying renal impairment. At the very least, diuretic therapy should be held or reduced when commencing an ACEI in a patient with renal impairment. Combination therapy with ACEI, diuretics and NSAIDs or COX-2 may be particularly harmful. Drugs, which are primarily excreted by the kidney (e.g. metformin, sotalol, cisapride, etc.) need to be used with caution in patients with renal impairment. The calculated GFR needs to be determined and the dose reduced or the drug avoided as appropriate. Cardiovascular disease (clinical) DSS Health, Superseded 01/09/2012 DSS specific information: Nephrotoxic agents (including radiocontrast) should be avoided where possible. Although combination ACEI and diuretic can be a very potent and efficacious means of reducing blood pressure (and thereby slowing progression), either drug should be introduced individually and carefully in a patient with underlying renal impairment. At the very least, diuretic therapy should be held or reduced when commencing an ACEI in a patient with renal impairment. Combination therapy with ACEI, diuretics and NSAIDs or COX-2 may be particularly harmful. Drugs, which are primarily excreted by the kidney (e.g. metformin, sotalol, cisapride, etc.) need to be used with caution in patients with renal impairment. The calculated GFR needs to be determined and the dose reduced or the drug avoided as appropriate. Cardiovascular disease (clinical) NBPDS Health, Superseded 17/10/2018 DSS specific information: Nephrotoxic agents (including radiocontrast) should be avoided where possible. Although combination ACEI and diuretic can be a very potent and efficacious means of reducing blood pressure (and thereby slowing progression), either drug should be introduced individually and carefully in a patient with underlying renal impairment. At the very least, diuretic therapy should be held or reduced when commencing an ACEI in a patient with renal impairment. Combination therapy with ACEI, diuretics and NSAIDs or COX-2 may be particularly harmful. Drugs, which are primarily excreted by the kidney (e.g. metformin, sotalol, cisapride, etc.) need to be used with caution in patients with renal impairment. The calculated GFR needs to be determined and the dose reduced or the drug avoided as appropriate. Cardiovascular disease (clinical) NBPDS Health, Standard 17/10/2018 DSS specific information: Nephrotoxic agents (including radiocontrast) should be avoided where possible. Although combination ACEI and diuretic can be a very potent and efficacious means of reducing blood pressure (and thereby slowing progression), either drug should be introduced individually and carefully in a patient with underlying renal impairment. At the very least, diuretic therapy should be held or reduced when commencing an ACEI in a patient with renal impairment. Combination therapy with ACEI, diuretics and NSAIDs or COX-2 may be particularly harmful. Drugs, which are primarily excreted by the kidney (e.g. metformin, sotalol, cisapride, etc.) need to be used with caution in patients with renal impairment. The calculated GFR needs to be determined and the dose reduced or the drug avoided as appropriate. |